1 | percentage | 13,401 |
2 | logarithm | 216 |
3 | logarithms | 18 |
4 | hugo | 4 |
5 | mg/kj | 4 |
6 | 'mcid | 3 |
7 | 0.35-fold | 3 |
8 | 168-day | 3 |
9 | baseline-to-exit | 3 |
10 | death-rate | 3 |
11 | 0.3-point | 2 |
12 | difference=2.7 | 2 |
13 | difference=3.0 | 2 |
14 | nine-tenths | 2 |
15 | non-planarity | 2 |
16 | preoperative-postoperative | 2 |
17 | +/-1,9 | 1 |
18 | -8·3 | 1 |
19 | -bands | 1 |
20 | /pulsatile | 1 |
21 | 0,3+/-1,6 | 1 |
22 | 0,8+/-6,5 | 1 |
23 | 33.9±5.8 | 1 |
24 | 4c-height | 1 |
25 | acetazolamide-induced | 1 |
26 | adcs-adlsev19 | 1 |
27 | anxiety/depression/impulsivity | 1 |
28 | at/different | 1 |
29 | av02 | 1 |
30 | covariable-adjusted | 1 |
31 | difference-from-baseline | 1 |
32 | difference=2.2 | 1 |
33 | difference=4.9 | 1 |
34 | dse/weight | 1 |
35 | effect-size-difference | 1 |
36 | effect=0.66 | 1 |
37 | effect=2.37 | 1 |
38 | epoetin-equivalent | 1 |
39 | ese/weight | 1 |
40 | exertion-evoked | 1 |
41 | five-shu | 1 |
42 | fold-differences | 1 |
43 | gp-induced | 1 |
44 | injury:3 | 1 |
45 | intestine-4 | 1 |
46 | osce-score | 1 |
47 | pacing-related | 1 |
48 | pcsas | 1 |
49 | plaque-ph | 1 |
50 | points/13 | 1 |
51 | postsampling | 1 |
52 | pre-test-to-post-test | 1 |
53 | pre/postrest | 1 |
54 | pretreatment/post-treatment | 1 |
55 | proteins-a | 1 |
56 | psc833-induced | 1 |
57 | riluzole-induced | 1 |
58 | score=100 | 1 |
59 | ser-79 | 1 |
60 | ser-81 | 1 |
61 | therapeutically-induced | 1 |
62 | tie-dependent | 1 |
63 | total-score | 1 |
64 | two-three-fold | 1 |
65 | underevaluation | 1 |
66 | vasoregulatory | 1 |
67 | year-over-year | 1 |
1 | 'mcid | 3 |
2 | +/-1,9 | 1 |
3 | -8·3 | 1 |
4 | -bands | 1 |
5 | /pulsatile | 1 |
6 | 0,3+/-1,6 | 1 |
7 | 0,8+/-6,5 | 1 |
8 | 0.3-point | 2 |
9 | 0.35-fold | 3 |
10 | 168-day | 3 |
11 | 33.9±5.8 | 1 |
12 | 4c-height | 1 |
13 | acetazolamide-induced | 1 |
14 | adcs-adlsev19 | 1 |
15 | anxiety/depression/impulsivity | 1 |
16 | at/different | 1 |
17 | av02 | 1 |
18 | baseline-to-exit | 3 |
19 | covariable-adjusted | 1 |
20 | death-rate | 3 |
21 | difference-from-baseline | 1 |
22 | difference=2.2 | 1 |
23 | difference=2.7 | 2 |
24 | difference=3.0 | 2 |
25 | difference=4.9 | 1 |
26 | dse/weight | 1 |
27 | effect-size-difference | 1 |
28 | effect=0.66 | 1 |
29 | effect=2.37 | 1 |
30 | epoetin-equivalent | 1 |
31 | ese/weight | 1 |
32 | exertion-evoked | 1 |
33 | five-shu | 1 |
34 | fold-differences | 1 |
35 | gp-induced | 1 |
36 | hugo | 4 |
37 | injury:3 | 1 |
38 | intestine-4 | 1 |
39 | logarithm | 216 |
40 | logarithms | 18 |
41 | mg/kj | 4 |
42 | nine-tenths | 2 |
43 | non-planarity | 2 |
44 | osce-score | 1 |
45 | pacing-related | 1 |
46 | pcsas | 1 |
47 | percentage | 13,401 |
48 | plaque-ph | 1 |
49 | points/13 | 1 |
50 | postsampling | 1 |
51 | pre-test-to-post-test | 1 |
52 | pre/postrest | 1 |
53 | preoperative-postoperative | 2 |
54 | pretreatment/post-treatment | 1 |
55 | proteins-a | 1 |
56 | psc833-induced | 1 |
57 | riluzole-induced | 1 |
58 | score=100 | 1 |
59 | ser-79 | 1 |
60 | ser-81 | 1 |
61 | therapeutically-induced | 1 |
62 | tie-dependent | 1 |
63 | total-score | 1 |
64 | two-three-fold | 1 |
65 | underevaluation | 1 |
66 | vasoregulatory | 1 |
67 | year-over-year | 1 |
1 | difference=3.0 | 2 |
2 | score=100 | 1 |
3 | ser-81 | 1 |
4 | difference=2.2 | 1 |
5 | av02 | 1 |
6 | points/13 | 1 |
7 | injury:3 | 1 |
8 | -8·3 | 1 |
9 | intestine-4 | 1 |
10 | 0,8+/-6,5 | 1 |
11 | 0,3+/-1,6 | 1 |
12 | effect=0.66 | 1 |
13 | difference=2.7 | 2 |
14 | effect=2.37 | 1 |
15 | 33.9±5.8 | 1 |
16 | +/-1,9 | 1 |
17 | difference=4.9 | 1 |
18 | adcs-adlsev19 | 1 |
19 | ser-79 | 1 |
20 | proteins-a | 1 |
21 | psc833-induced | 1 |
22 | acetazolamide-induced | 1 |
23 | riluzole-induced | 1 |
24 | gp-induced | 1 |
25 | therapeutically-induced | 1 |
26 | exertion-evoked | 1 |
27 | pacing-related | 1 |
28 | covariable-adjusted | 1 |
29 | 'mcid | 3 |
30 | 0.35-fold | 3 |
31 | two-three-fold | 1 |
32 | effect-size-difference | 1 |
33 | percentage | 13,401 |
34 | /pulsatile | 1 |
35 | difference-from-baseline | 1 |
36 | osce-score | 1 |
37 | total-score | 1 |
38 | death-rate | 3 |
39 | preoperative-postoperative | 2 |
40 | postsampling | 1 |
41 | plaque-ph | 1 |
42 | mg/kj | 4 |
43 | logarithm | 216 |
44 | underevaluation | 1 |
45 | hugo | 4 |
46 | year-over-year | 1 |
47 | pcsas | 1 |
48 | -bands | 1 |
49 | fold-differences | 1 |
50 | nine-tenths | 2 |
51 | logarithms | 18 |
52 | 4c-height | 1 |
53 | dse/weight | 1 |
54 | ese/weight | 1 |
55 | baseline-to-exit | 3 |
56 | tie-dependent | 1 |
57 | epoetin-equivalent | 1 |
58 | pretreatment/post-treatment | 1 |
59 | at/different | 1 |
60 | 0.3-point | 2 |
61 | pre/postrest | 1 |
62 | pre-test-to-post-test | 1 |
63 | five-shu | 1 |
64 | 168-day | 3 |
65 | vasoregulatory | 1 |
66 | non-planarity | 2 |
67 | anxiety/depression/impulsivity | 1 |